Basit öğe kaydını göster

dc.contributor.authorSiperstein, AE
dc.contributor.authorClark, OH
dc.contributor.authorDuh, QY
dc.contributor.authorWong, MG
dc.contributor.authorTezelman, S
dc.date.accessioned2021-03-03T18:23:12Z
dc.date.available2021-03-03T18:23:12Z
dc.date.issued1996
dc.identifier.citationTezelman S., Siperstein A., Duh Q., Wong M., Clark O., "Desensitization of cyclic adenosine 3,5'-monophosphate response to thyrotropin in normal and primary or metastatic papillary thyroid cancer cells in vitro", SURGERY, cilt.120, sa.6, ss.926-933, 1996
dc.identifier.issn0039-6060
dc.identifier.otherav_4ec17ece-68fd-4fed-8f77-33f8032d7668
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/56238
dc.identifier.urihttps://doi.org/10.1016/s0039-6060(96)80035-3
dc.description.abstractBackground, Desensitization is an important physiologic process resulting in a decreased functional response after continuous or repeated stimulation. Prior exposure of normal human thyroid tissue to thyrotropin either in vivo or in vitro causes desensitization of adenylate cyclase. Little is known, however, about whether the thyrotropin-adenylate cyclase-cyclic adenosine 3,5'-monophosphate (cAMP) signal transduction system desensitizes in human thyroid carcinomas. Failure to desensitize could result in increased growth or metastases.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectCerrahi Tıp Bilimleri
dc.titleDesensitization of cyclic adenosine 3,5'-monophosphate response to thyrotropin in normal and primary or metastatic papillary thyroid cancer cells in vitro
dc.typeMakale
dc.relation.journalSURGERY
dc.contributor.department, ,
dc.identifier.volume120
dc.identifier.issue6
dc.identifier.startpage926
dc.identifier.endpage933
dc.contributor.firstauthorID118136


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster